These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 31514068)

  • 1. LINC01210 accelerates proliferation, invasion and migration in ovarian cancer through epigenetically downregulating KLF4.
    Zhang C; Liu J; Zhang Y; Luo C; Zhu T; Zhang R; Yao R
    Biomed Pharmacother; 2019 Nov; 119():109431. PubMed ID: 31514068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LINC00702 accelerates the progression of ovarian cancer through interacting with EZH2 to inhibit the transcription of KLF2.
    Wang L; Ye TY; Wu H; Chen SY; Weng JR; Xi XW
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):201-208. PubMed ID: 31389610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNA SNGH7 Is activated by SP1 and exerts oncogenic properties by interacting with EZH2 in ovarian cancer.
    Bai Z; Wu Y; Bai S; Yan Y; Kang H; Ma W; Zhang J; Gao Y; Hui B; Ma H; Li R; Zhang X; Ren J
    J Cell Mol Med; 2020 Jul; 24(13):7479-7489. PubMed ID: 32420685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long noncoding RNA ATB promotes ovarian cancer tumorigenesis by mediating histone H3 lysine 27 trimethylation through binding to EZH2.
    Chen XJ; An N
    J Cell Mol Med; 2021 Jan; 25(1):37-46. PubMed ID: 33336896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA DANCR aggravates the progression of ovarian cancer by downregulating UPF1.
    Pei CL; Fei KL; Yuan XY; Gong XJ
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10657-10663. PubMed ID: 31858532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LINC01210 promotes malignant phenotypes of colorectal cancer through epigenetically upregulating SRSF3.
    Luo J; Gao K; Chen M; Tian B
    Pathol Res Pract; 2022 Jun; 234():153905. PubMed ID: 35462226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA DLEU2 aggravates the progression of hepatocellular carcinoma through binding to EZH2.
    Guo Y; Bai M; Lin L; Huang J; An Y; Liang L; Liu Y; Huang W
    Biomed Pharmacother; 2019 Oct; 118():109272. PubMed ID: 31376657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LINC01116 promotes proliferation, invasion and migration of osteosarcoma cells by silencing p53 and EZH2.
    Zhang ZF; Xu HH; Hu WH; Hu TY; Wang XB
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6813-6823. PubMed ID: 31486480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LINC01308 accelerates the malignant progression of ovarian cancer by binding to miRNA-506.
    Zhang YY; Li P; Zhu MZ; Guo Y; Yang J
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3253-3260. PubMed ID: 31081077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA SNHG12 accelerates the progression of ovarian cancer via absorbing miRNA-129 to upregulate SOX4.
    Sun D; Fan XH
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2345-2352. PubMed ID: 30964158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LINC00511 promotes the progression of non-small cell lung cancer through downregulating LATS2 and KLF2 by binding to EZH2 and LSD1.
    Zhu FY; Zhang SR; Wang LH; Wu WD; Zhao H
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8377-8390. PubMed ID: 31646568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long noncoding RNA GIHCG promotes hepatocellular carcinoma progression through epigenetically regulating miR-200b/a/429.
    Sui CJ; Zhou YM; Shen WF; Dai BH; Lu JJ; Zhang MF; Yang JM
    J Mol Med (Berl); 2016 Nov; 94(11):1281-1296. PubMed ID: 27380494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA FAM83H-AS1 contributes to the radioresistance, proliferation, and metastasis in ovarian cancer through stabilizing HuR protein.
    Dou Q; Xu Y; Zhu Y; Hu Y; Yan Y; Yan H
    Eur J Pharmacol; 2019 Jun; 852():134-141. PubMed ID: 30831080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA XIST facilitates cell growth, migration and invasion via modulating H3 histone methylation of DKK1 in neuroblastoma.
    Zhang J; Li WY; Yang Y; Yan LZ; Zhang SY; He J; Wang JX
    Cell Cycle; 2019 Aug; 18(16):1882-1892. PubMed ID: 31208278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding RNA XIST acts as an oncogene in non-small cell lung cancer by epigenetically repressing KLF2 expression.
    Fang J; Sun CC; Gong C
    Biochem Biophys Res Commun; 2016 Sep; 478(2):811-7. PubMed ID: 27501756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TRIM24 aggravates the progression of ovarian cancer through negatively regulating FOXM1 level.
    Zhou HE; Pan SS; Han H
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10647-10656. PubMed ID: 31858531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LINC01342 promotes the progression of ovarian cancer by absorbing microRNA-30c-2-3p to upregulate HIF3A.
    Zhang C; Liu J; Zhang Y; Luo C; Zhu T; Zhang R; Yao R
    J Cell Physiol; 2020 Apr; 235(4):3939-3949. PubMed ID: 31595977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNA AFAP1-AS1 promotes proliferation and migration of gastric cancer by downregulating KLF2.
    Yuan XH; Li J; Cao Y; Jie ZG; Zeng YF
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):673-680. PubMed ID: 32016968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Linc-UBC1 stimulates the metastasis and progression of ovarian cancer via downregulating p53 level.
    Liu H; Zeng SY; Xie Y; Fei CQ; Sun L
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1054-1061. PubMed ID: 32096175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The carcinogenic complex lncRNA DUXAP8/EZH2/LSD1 accelerates the proliferation, migration and invasion of colorectal cancer.
    Gong A; Huang Z; Ge H; Cai Y; Yang C
    J BUON; 2019; 24(5):1830-1836. PubMed ID: 31786844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.